Sector · updated 2026-05-28
195 Healthcare stocks down from a 52-week high.
Across Healthcare, 89 names are on the Red List, 47 on Amber, and 59 on Watch. The median Healthcare decline is -36.0%. Worst in sector: OPRX (-77.1%). Tiering is computed daily from decline depth, decline sigma, and time-frame continuity — price action only, not fundamentals.
89Red List
47Amber
59Watch
| Tier | Ticker | Company | Decline | Sigma | TFC | Price | Trigger |
|---|---|---|---|---|---|---|---|
| Red List |  OPRX |
OptimizeRx Corporation | -77.1% | 5.1σ | 2/5 | $5.10 | decline depth |
| Red List |  KRRO |
Korro Bio, Inc. | -76.0% | 1.0σ | 2/5 | $13.40 | decline depth |
| Red List |  UPB |
Upstream Bio, Inc. | -75.3% | 4.9σ | 4/5 | $8.32 | decline depth |
| Red List |  DOCS |
Doximity, Inc. | -72.5% | 3.8σ | 3/5 | $21.07 | decline depth |
| Red ListRecovering |  PHR |
Phreesia, Inc. | -71.2% | 5.1σ | 4/5 | $9.45 | decline depth |
| Red List |  WGS |
GeneDx Holdings Corp. | -70.7% | 2.5σ | 4/5 | $50.15 | decline depth |
| Red ListRecovering |  WVE |
Wave Life Sciences Ltd. | -70.2% | 6.7σ | 3/5 | $6.47 | decline depth |
| Red ListRecovering |  MLTX |
MoonLake Immunotherapeutics | -70.2% | 3.1σ | 1/5 | $18.68 | decline depth |
| Red ListRecovering |  ARCT |
Arcturus Therapeutics Holdings | -67.2% | 4.9σ | 2/5 | $7.92 | decline depth |
| Red List |  ATEC |
Alphatec Holdings, Inc. | -66.1% | 3.4σ | 4/5 | $7.89 | decline depth |
| Red List |  RXST |
RxSight, Inc. | -66.1% | 5.7σ | 5/5 | $5.59 | decline depth |
| Red ListRecovering |  QURE |
uniQure N.V. | -65.2% | 2.8σ | 2/5 | $24.85 | decline depth |
| Red List |  OLMA |
Olema Pharmaceuticals, Inc. | -64.8% | 6.7σ | 3/5 | $12.76 | decline depth |
| Red List |  ADMA |
ADMA Biologics Inc | -64.5% | 6.4σ | 5/5 | $7.93 | decline depth |
| Red ListRecovering |  HIMS |
Hims & Hers Health, Inc. | -64.0% | 3.6σ | 4/5 | $25.38 | decline depth |
| Red ListRecovering |  QDEL |
QuidelOrtho Corporation | -63.3% | 2.0σ | 3/5 | $13.07 | decline depth |
| Red List |  CRBP |
Corbus Pharmaceuticals Holdings | -62.8% | 4.6σ | 2/5 | $7.64 | decline depth |
| Red ListRecovering |  SRPT |
Sarepta Therapeutics, Inc. | -60.6% | 8.3σ | 1/5 | $17.30 | decline depth |
| Red List |  NERV |
Minerva Neurosciences, Inc | -59.9% | 4.5σ | 2/5 | $5.00 | decline depth |
| Red List |  PODD |
Insulet Corporation | -59.8% | 5.3σ | 4/5 | $142.65 | decline depth |
| Red ListRecovering |  CLPT |
ClearPoint Neuro Inc. | -59.3% | 3.7σ | 3/5 | $12.24 | decline depth |
| Red ListRecovering |  PRCT |
PROCEPT BioRobotics Corporation | -59.3% | 2.7σ | 3/5 | $27.20 | decline depth |
| Red List |  CERT |
Certara, Inc. | -59.1% | 3.1σ | 4/5 | $5.67 | decline depth |
| Red List |  ZBIO |
Zenas BioPharma, Inc. | -58.4% | 3.5σ | 2/5 | $18.56 | decline depth |
| Red ListRecovering |  PRGO |
Perrigo Company plc | -58.4% | 4.0σ | 3/5 | $11.44 | decline depth |
| Red ListRecovering |  JANX |
Janux Therapeutics, Inc. | -58.3% | 2.2σ | 4/5 | $14.74 | decline depth |
| Red ListRecovering |  RGNX |
REGENXBIO Inc. | -57.4% | 4.1σ | 3/5 | $6.89 | decline depth |
| Red ListRecovering |  FULC |
Fulcrum Therapeutics, Inc. | -56.7% | 3.3σ | 4/5 | $6.82 | decline depth |
| Red List |  TMDX |
TransMedics Group, Inc. | -56.5% | 5.6σ | 3/5 | $67.83 | decline depth |
| Red List |  BSX |
Boston Scientific Corporation | -55.1% | 4.9σ | 5/5 | $49.11 | decline depth |
| Red List |  ZTS |
Zoetis Inc. | -53.9% | 6.1σ | 5/5 | $78.27 | decline depth |
| Red ListRecovering |  RNAC |
Cartesian Therapeutics, Inc. | -53.7% | 4.4σ | 3/5 | $7.21 | decline depth |
| Red List |  CRVS |
Corvus Pharmaceuticals, Inc. | -53.6% | 5.0σ | 2/5 | $12.50 | decline depth |
| Red List |  WAY |
Waystar Holding Corp. | -53.3% | 4.3σ | 4/5 | $19.39 | decline depth |
| Red ListRecovering |  AORT |
Artivion, Inc. | -53.2% | 5.8σ | 3/5 | $22.57 | decline depth |
| Red ListRecovering |  CRMD |
CorMedix Inc. | -51.7% | 2.3σ | 2/5 | $8.42 | decline depth |
| Red ListRecovering |  NTLA |
Intellia Therapeutics, Inc. | -51.6% | 3.4σ | 2/5 | $13.68 | decline depth |
| Red ListRecovering |  TEM |
Tempus AI, Inc. | -50.8% | 4.1σ | 2/5 | $51.29 | decline depth |
| Red List |  ACET |
Adicet Bio, Inc. | -50.5% | 1.7σ | 3/5 | $8.64 | decline depth |
| Red ListRecovering |  SPRY |
ARS Pharmaceuticals, Inc. | -50.3% | 2.1σ | 3/5 | $9.40 | decline depth |
| Red List |  CVRX |
CVRx, Inc. | -50.2% | 4.6σ | 2/5 | $5.63 | decline depth |
| Red ListRecovering |  CSTL |
Castle Biosciences, Inc. | -50.1% | 3.0σ | 2/5 | $22.11 | decline depth |
| Red List |  ERAS |
Erasca, Inc. | -49.8% | 1.1σ | 1/5 | $12.20 | decline depth |
| Red ListRecovering |  KROS |
Keros Therapeutics, Inc. | -49.5% | 2.3σ | 2/5 | $11.39 | decline depth |
| Red ListRecovering |  VRDN |
Viridian Therapeutics, Inc. | -49.1% | 1.7σ | 3/5 | $17.45 | decline depth |
| Red ListRecovering |  INSM |
Insmed Incorporated | -49.1% | 4.0σ | 3/5 | $108.37 | decline depth |
| Red ListRecovering |  SLP |
Simulations Plus, Inc. | -48.8% | 2.4σ | 4/5 | $16.71 | decline depth |
| Red ListRecovering |  SDGR |
Schrodinger, Inc. | -48.8% | 2.7σ | 4/5 | $14.16 | decline depth |
| Red ListRecovering |  VEEV |
Veeva Systems Inc. | -47.1% | 3.2σ | 4/5 | $164.38 | decline depth |
| Red List |  PAHC |
Phibro Animal Health Corporatio | -47.0% | 7.0σ | 0/5 | $31.83 | decline depth |
| Red ListRecovering |  DNA |
Ginkgo Bioworks Holdings, Inc. | -46.2% | 2.7σ | 2/5 | $9.46 | decline depth |
| Red List |  AZTA |
Azenta, Inc. | -46.1% | 2.4σ | 4/5 | $22.49 | decline depth |
| Red List |  IRTC |
iRhythm Holdings, Inc. | -45.5% | 4.6σ | 3/5 | $115.61 | decline depth |
| Red List |  RARE |
Ultragenyx Pharmaceutical Inc. | -45.1% | 6.6σ | 5/5 | $23.26 | decline depth |
| Red ListRecovering |  BHVN |
Biohaven Ltd. | -44.9% | 2.2σ | 3/5 | $10.24 | decline depth |
| Red ListRecovering |  PBH |
Prestige Consumer Healthcare In | -44.4% | 5.3σ | 2/5 | $48.47 | decline depth |
| Red ListRecovering |  OCUL |
Ocular Therapeutix, Inc. | -44.3% | 4.4σ | 3/5 | $9.15 | decline depth |
| Red List |  OFIX |
Orthofix Medical Inc. | -44.1% | 6.3σ | 3/5 | $9.49 | decline depth |
| Red ListRecovering |  VTYX |
Ventyx Biosciences, Inc. | -44.0% | — | 0/5 | $14.00 | decline depth |
| Red ListRecovering |  SMMT |
Summit Therapeutics Inc. | -43.8% | 3.7σ | 3/5 | $17.41 | decline depth |
| Red List |  PHAT |
Phathom Pharmaceuticals, Inc. | -43.6% | 5.7σ | 4/5 | $10.32 | decline depth |
| Red List |  TNDM |
Tandem Diabetes Care, Inc. | -43.6% | 4.4σ | 1/5 | $16.72 | decline depth |
| Red List |  ORIC |
Oric Pharmaceuticals, Inc. | -43.4% | 6.4σ | 2/5 | $8.45 | decline depth |
| Red ListRecovering |  SGRY |
Surgery Partners, Inc. | -43.4% | 7.3σ | 3/5 | $13.65 | decline depth |
| Red ListRecovering |  MOH |
Molina Healthcare Inc | -42.9% | 6.3σ | 3/5 | $178.02 | decline depth |
| Red ListRecovering |  WEAV |
Weave Communications, Inc. | -42.6% | 2.3σ | 5/5 | $5.76 | decline depth |
| Red ListRecovering |  AVTR |
Avantor, Inc. | -42.6% | 3.0σ | 4/5 | $9.15 | decline depth |
| Red ListRecovering |  RIGL |
Rigel Pharmaceuticals, Inc. | -42.5% | 2.5σ | 3/5 | $30.05 | decline depth |
| Red ListRecovering |  NVO |
Novo Nordisk A/S | -41.4% | 4.2σ | 3/5 | $45.51 | decline depth |
| Red ListRecovering |  OPCH |
Option Care Health, Inc. | -41.4% | 0.8σ | 2/5 | $21.58 | decline depth |
| Red ListRecovering |  SLNO |
Soleno Therapeutics, Inc. | -41.3% | 0.6σ | 5/5 | $53.01 | decline depth |
| Red ListRecovering |  FLGT |
Fulgent Genetics, Inc. | -41.2% | 1.2σ | 3/5 | $18.24 | decline depth |
| Red ListRecovering |  ATRA |
Atara Biotherapeutics, Inc. | -41.2% | 0.9σ | 3/5 | $11.26 | decline depth |
| Red ListRecovering |  DMAC |
DiaMedica Therapeutics Inc. | -40.9% | 2.9σ | 2/5 | $6.16 | decline depth |
| Red List |  CNMD |
CONMED Corporation | -40.7% | 4.9σ | 5/5 | $35.52 | decline depth |
| Red List |  ARVN |
Arvinas, Inc. | -39.1% | 7.5σ | 3/5 | $8.84 | decline depth |
| Red List |  UHS |
Universal Health Services, Inc. | -39.1% | 12.2σ | 4/5 | $150.12 | decline sigma |
| Red ListRecovering |  IBRX |
ImmunityBio, Inc. | -37.9% | 2.4σ | 2/5 | $7.72 | decline depth |
| Red List |  OMER |
Omeros Corporation | -36.8% | 9.0σ | 3/5 | $11.15 | decline sigma |
| Red List |  ORKA |
Oruka Therapeutics, Inc. | -36.3% | 5.1σ | 1/5 | $57.98 | decline depth |
| Red List |  MMSI |
Merit Medical Systems, Inc. | -34.1% | 3.4σ | 5/5 | $63.75 | time-frame continuity |
| Red ListRecovering |  VNDA |
Vanda Pharmaceuticals Inc. | -33.2% | 4.2σ | 2/5 | $6.64 | decline depth |
| Red List |  INBX |
Inhibrx Biosciences, Inc. | -33.0% | 5.1σ | 3/5 | $103.98 | decline depth |
| Red ListRecovering |  TCMD |
Tactile Systems Technology, Inc | -32.4% | 3.4σ | 1/5 | $25.55 | decline depth |
| Red List |  HCA |
HCA Healthcare, Inc. | -30.9% | 9.9σ | 3/5 | $384.39 | decline depth |
| Red List |  ALMS |
Alumis Inc. | -30.1% | 5.2σ | 3/5 | $21.40 | decline depth |
| Red ListRecovering |  CHE |
Chemed Corp | -23.9% | 4.3σ | 5/5 | $439.89 | time-frame continuity |
| Red List |  SYK |
Stryker Corporation | -23.4% | 2.6σ | 5/5 | $307.63 | time-frame continuity |
| Red ListRecovering |  NVST |
Envista Holdings Corporation | -22.2% | 8.0σ | 1/5 | $23.67 | decline sigma |
| Amber ListRecovering |  SPOK |
Spok Holdings, Inc. | -39.8% | 4.2σ | 3/5 | $10.56 | decline depth |
| Amber ListRecovering |  BAX |
Baxter International Inc. | -39.4% | 2.9σ | 4/5 | $19.25 | decline depth |
| Amber ListRecovering |  ARDT |
Ardent Health, Inc. | -38.9% | 3.7σ | 3/5 | $9.46 | decline depth |
| Amber ListRecovering |  ALNY |
Alnylam Pharmaceuticals, Inc. | -38.4% | 4.0σ | 3/5 | $305.06 | decline depth |
| Amber ListRecovering |  AMPH |
Amphastar Pharmaceuticals, Inc. | -38.3% | 3.9σ | 4/5 | $19.30 | decline depth |
| Amber ListRecovering |  EOLS |
Evolus, Inc. Common Stock | -38.1% | 2.1σ | 4/5 | $6.57 | decline depth |
| Amber ListRecovering |  XRAY |
DENTSPLY SIRONA Inc. | -38.1% | 7.5σ | 1/5 | $10.29 | decline depth |
| Amber List |  CRNX |
Crinetics Pharmaceuticals, Inc. | -37.9% | 4.2σ | 3/5 | $36.01 | decline depth |
| Amber ListRecovering |  GRAL |
GRAIL, Inc. | -37.8% | 2.2σ | 2/5 | $73.92 | decline depth |
| Amber List |  BHC |
Bausch Health Companies Inc. | -37.7% | 6.9σ | 4/5 | $5.41 | decline depth |
| Amber List |  ENOV |
Enovis Corporation | -37.4% | 4.4σ | 3/5 | $23.04 | decline depth |
| Amber ListRecovering |  XERS |
Xeris Biopharma Holdings, Inc. | -37.3% | 4.2σ | 4/5 | $6.32 | decline depth |
| Amber ListRecovering |  DCTH |
Delcath Systems, Inc. | -36.9% | 4.8σ | 1/5 | $10.95 | decline depth |
| Amber List |  ABT |
Abbott Laboratories | -36.7% | 4.3σ | 4/5 | $86.30 | decline depth |
| Amber ListRecovering |  QGEN |
Qiagen N.V. | -36.6% | 1.7σ | 4/5 | $36.64 | decline depth |
| Amber List |  TENX |
Tenax Therapeutics, Inc. | -36.4% | 5.6σ | 2/5 | $11.69 | decline depth |
| Amber ListRecovering |  VERA |
Vera Therapeutics, Inc. | -36.0% | 4.3σ | 2/5 | $35.86 | decline depth |
| Amber ListRecovering |  XNCR |
Xencor, Inc. | -36.0% | 4.3σ | 4/5 | $11.97 | decline depth |
| Amber ListRecovering |  RDNT |
RadNet, Inc. | -35.6% | 7.5σ | 4/5 | $55.31 | decline depth |
| Amber ListRecovering |  HROW |
Harrow, Inc. | -35.5% | 3.2σ | 2/5 | $35.39 | decline depth |
| Amber ListRecovering |  ICLR |
ICON plc | -35.2% | 3.6σ | 2/5 | $136.80 | decline depth |
| Amber List |  ATRC |
AtriCure, Inc. | -35.0% | 3.0σ | 3/5 | $28.09 | decline depth |
| Amber ListRecovering |  EBS |
Emergent BioSolutions Inc. | -34.7% | 2.7σ | 3/5 | $9.18 | decline depth |
| Amber List |  IVA |
Inventiva S.A. - American Depos | -34.5% | 4.0σ | 2/5 | $5.23 | decline depth |
| Amber List |  COLL |
Collegium Pharmaceutical, Inc. | -34.3% | 6.7σ | 3/5 | $33.37 | decline depth |
| Amber ListRecovering |  AGIO |
Agios Pharmaceuticals, Inc. | -33.9% | 3.3σ | 2/5 | $30.42 | decline depth |
| Amber ListRecovering |  MLYS |
Mineralys Therapeutics, Inc. | -33.8% | 1.8σ | 4/5 | $31.54 | decline depth |
| Amber List |  ALHC |
Alignment Healthcare, Inc. | -33.5% | 7.2σ | 3/5 | $15.87 | decline depth |
| Amber ListRecovering |  STVN |
Stevanato Group S.p.A. | -33.4% | 2.1σ | 4/5 | $18.66 | decline depth |
| Amber ListRecovering |  ARQT |
Arcutis Biotherapeutics, Inc. | -32.5% | 3.0σ | 3/5 | $21.44 | decline depth |
| Amber List |  COO |
The Cooper Companies, Inc. | -32.0% | 3.8σ | 3/5 | $61.04 | decline depth |
| Amber ListRecovering |  USPH |
U.S. Physical Therapy, Inc. | -30.3% | 3.4σ | 2/5 | $63.89 | decline depth |
| Amber List |  RMD |
ResMed Inc. | -30.2% | 3.3σ | 3/5 | $203.42 | decline depth |
| Amber ListRecovering |  RGEN |
Repligen Corporation | -30.2% | 3.8σ | 3/5 | $122.73 | decline depth |
| Amber List |  TARS |
Tarsus Pharmaceuticals, Inc. | -30.2% | 3.5σ | 2/5 | $59.54 | decline depth |
| Amber List |  ATR |
AptarGroup, Inc. | -28.6% | 7.2σ | 2/5 | $115.99 | decline sigma |
| Amber ListRecovering |  CRSP |
CRISPR Therapeutics AG | -28.2% | 2.6σ | 4/5 | $56.38 | time-frame continuity |
| Amber ListRecovering |  IDXX |
IDEXX Laboratories, Inc. | -26.2% | 3.3σ | 4/5 | $568.03 | time-frame continuity |
| Amber ListRecovering |  DHR |
Danaher Corporation | -25.6% | 2.2σ | 4/5 | $180.63 | time-frame continuity |
| Amber List |  VCEL |
Vericel Corporation | -25.5% | 7.0σ | 1/5 | $34.24 | decline sigma |
| Amber List |  ADUS |
Addus HomeCare Corporation | -24.8% | 5.9σ | 4/5 | $93.53 | time-frame continuity |
| Amber List |  KOD |
Kodiak Sciences Inc | -24.5% | 7.2σ | 2/5 | $36.12 | decline sigma |
| Amber ListRecovering |  RYTM |
Rhythm Pharmaceuticals, Inc. | -23.9% | 2.4σ | 4/5 | $92.98 | time-frame continuity |
| Amber ListRecovering |  ZBH |
Zimmer Biomet Holdings, Inc. | -22.9% | 3.6σ | 4/5 | $82.82 | time-frame continuity |
| Amber List |  ENTA |
Enanta Pharmaceuticals, Inc. | -22.9% | 7.0σ | 3/5 | $13.23 | decline sigma |
| Amber List |  ENSG |
The Ensign Group, Inc. | -21.6% | 7.1σ | 1/5 | $170.94 | decline sigma |
| Amber ListRecovering |  BDX |
Becton, Dickinson and Company | -20.3% | 3.2σ | 4/5 | $148.41 | time-frame continuity |
| Watch |  THC |
Tenet Healthcare Corporation | -29.9% | 5.8σ | 2/5 | $173.20 | decline depth |
| Watch |  GEHC |
GE HealthCare Technologies Inc. | -29.9% | 2.8σ | 2/5 | $62.86 | decline depth |
| Watch |  ISRG |
Intuitive Surgical, Inc. | -29.9% | 4.5σ | 2/5 | $423.63 | decline depth |
| WatchRecovering |  INNV |
InnovAge Holding Corp. | -29.8% | 5.5σ | 1/5 | $7.51 | decline depth |
| Watch |  TNGX |
Tango Therapeutics, Inc. | -29.6% | 4.4σ | 1/5 | $20.00 | decline depth |
| WatchRecovering |  EYPT |
EyePoint, Inc. | -29.4% | 3.7σ | 3/5 | $13.50 | decline depth |
| WatchRecovering |  TECH |
Bio-Techne Corp | -29.3% | 3.1σ | 3/5 | $50.84 | decline depth |
| Watch |  AVAH |
Aveanna Healthcare Holdings Inc | -29.0% | 3.3σ | 3/5 | $7.33 | decline depth |
| WatchRecovering |  BIOA |
BioAge Labs, Inc. | -29.0% | 2.9σ | 3/5 | $17.05 | decline depth |
| WatchRecovering |  IRON |
Disc Medicine, Inc. | -28.8% | 2.4σ | 2/5 | $70.80 | decline depth |
| Watch |  COR |
Cencora, Inc. | -28.8% | 3.5σ | 3/5 | $267.71 | decline depth |
| WatchRecovering |  MEDP |
Medpace Holdings, Inc. | -28.8% | 4.1σ | 1/5 | $448.12 | decline depth |
| Watch |  ALC |
Alcon Inc. | -28.7% | 4.1σ | 3/5 | $65.66 | decline depth |
| Watch |  INGN |
Inogen, Inc | -28.4% | 5.3σ | 2/5 | $6.54 | decline depth |
| Watch |  CAPR |
Capricor Therapeutics, Inc. | -27.9% | 3.6σ | 1/5 | $29.11 | decline depth |
| Watch |  MDT |
Medtronic plc. | -27.8% | 4.8σ | 3/5 | $75.57 | decline depth |
| WatchRecovering |  VREX |
Varex Imaging Corporation | -27.8% | 3.5σ | 3/5 | $10.52 | decline depth |
| Watch |  SVRA |
Savara, Inc. | -27.3% | 2.1σ | 3/5 | $5.09 | decline depth |
| WatchRecovering |  FDMT |
4D Molecular Therapeutics, Inc. | -27.3% | 5.1σ | 2/5 | $8.97 | decline depth |
| WatchRecovering |  ITGR |
Integer Holdings Corporation | -27.2% | 1.7σ | 1/5 | $90.05 | decline depth |
| Watch |  ADPT |
Adaptive Biotechnologies Corpor | -26.8% | 2.4σ | 3/5 | $15.19 | decline depth |
| WatchRecovering |  IQV |
IQVIA Holdings, Inc. | -26.7% | 3.1σ | 2/5 | $181.09 | decline depth |
| WatchRecovering |  NEO |
NeoGenomics, Inc. | -25.8% | 2.7σ | 3/5 | $10.19 | decline depth |
| WatchRecovering |  DYN |
Dyne Therapeutics, Inc. | -25.8% | 1.3σ | 2/5 | $18.56 | decline depth |
| WatchRecovering |  ARDX |
Ardelyx, Inc. | -25.6% | 5.1σ | 3/5 | $6.25 | decline depth |
| Watch |  JBIO |
Jade Biosciences, Inc. | -25.6% | 5.9σ | 3/5 | $20.84 | decline depth |
| WatchRecovering |  VKTX |
Viking Therapeutics, Inc. | -25.4% | 1.3σ | 2/5 | $32.19 | decline depth |
| WatchRecovering |  IDYA |
IDEAYA Biosciences, Inc. | -25.3% | 2.1σ | 2/5 | $29.34 | decline depth |
| Watch |  ANNX |
Annexon, Inc. | -25.2% | 4.2σ | 2/5 | $5.37 | decline depth |
| WatchRecovering |  CORT |
Corcept Therapeutics Incorporat | -24.9% | 1.4σ | 3/5 | $68.38 | decline depth |
| WatchRecovering |  KIDS |
OrthoPediatrics Corp. | -24.9% | 3.3σ | 2/5 | $17.81 | decline depth |
| WatchRecovering |  GLUE |
Monte Rosa Therapeutics, Inc. | -24.8% | 3.6σ | 3/5 | $19.39 | decline depth |
| WatchRecovering |  TMO |
Thermo Fisher Scientific Inc | -24.3% | 2.7σ | 2/5 | $487.22 | decline depth |
| Watch |  MCK |
McKesson Corporation | -24.2% | 4.0σ | 2/5 | $756.98 | decline depth |
| Watch |  REGN |
Regeneron Pharmaceuticals, Inc. | -24.1% | 5.6σ | 2/5 | $621.52 | decline depth |
| Watch |  BKD |
Brookdale Senior Living Inc. | -23.8% | 5.4σ | 2/5 | $13.03 | decline depth |
| WatchRecovering |  MTD |
Mettler-Toledo International, I | -23.7% | 4.1σ | 2/5 | $1,163.50 | decline depth |
| WatchRecovering |  ACAD |
ACADIA Pharmaceuticals Inc. | -23.7% | 4.2σ | 2/5 | $21.63 | decline depth |
| WatchRecovering |  AMLX |
Amylyx Pharmaceuticals, Inc. | -23.6% | 5.8σ | 2/5 | $14.22 | decline depth |
| Watch |  ABEO |
Abeona Therapeutics Inc. | -23.3% | 2.1σ | 3/5 | $5.78 | decline depth |
| Watch |  CBLL |
CeriBell, Inc. | -23.3% | 2.3σ | 1/5 | $18.67 | decline depth |
| Watch |  HAE |
Haemonetics Corporation | -23.2% | 1.1σ | 2/5 | $67.04 | decline depth |
| WatchRecovering |  TDOC |
Teladoc Health, Inc. | -23.1% | 3.3σ | 2/5 | $7.51 | decline depth |
| WatchRecovering |  HRMY |
Harmony Biosciences Holdings, I | -22.9% | 3.4σ | 2/5 | $31.49 | decline depth |
| Watch |  TBPH |
Theravance Biopharma, Inc. | -22.9% | 5.9σ | 2/5 | $16.21 | decline depth |
| Watch |  SNDX |
Syndax Pharmaceuticals, Inc. | -22.8% | 4.1σ | 1/5 | $19.75 | decline depth |
| WatchRecovering |  HQY |
HealthEquity, Inc. | -22.4% | 3.2σ | 2/5 | $90.52 | decline depth |
| Watch |  SUPN |
Supernus Pharmaceuticals, Inc. | -21.5% | 5.9σ | 1/5 | $46.85 | decline depth |
| WatchRecovering |  NRIX |
Nurix Therapeutics, Inc. | -21.5% | 1.9σ | 3/5 | $17.67 | decline depth |
| Watch |  PCVX |
Vaxcyte, Inc. | -21.4% | 4.5σ | 1/5 | $51.06 | decline depth |
| Watch |  SNN |
Smith & Nephew SNATS, Inc. | -21.4% | 3.8σ | 2/5 | $29.77 | decline depth |
| WatchRecovering |  STOK |
Stoke Therapeutics, Inc. | -21.4% | 4.9σ | 1/5 | $31.61 | decline depth |
| Watch |  KYMR |
Kymera Therapeutics, Inc. | -20.9% | 4.5σ | 2/5 | $81.46 | decline depth |
| WatchRecovering |  PHG |
Koninklijke Philips N.V. NY Reg | -20.9% | 3.1σ | 3/5 | $26.45 | decline depth |
| WatchRecovering |  CRL |
Charles River Laboratories Inte | -20.8% | 4.0σ | 1/5 | $181.34 | decline depth |
| WatchRecovering |  SHC |
Sotera Health Company | -20.6% | 3.2σ | 3/5 | $15.75 | decline depth |
| Watch |  BMRN |
BioMarin Pharmaceutical Inc. | -20.4% | 3.5σ | 3/5 | $52.74 | decline depth |
| Watch |  KURA |
Kura Oncology, Inc. | -20.2% | 2.9σ | 3/5 | $9.97 | decline depth |
| Watch |  MRNA |
Moderna, Inc. | -20.1% | 5.9σ | 1/5 | $47.57 | decline depth |
195 Healthcare listings. Open in the full filterable list →
← All sectors Just the 11 Healthcare falling knives → The full list →